Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Thrombosis and Haemostasis|May 5, 2023
Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 RegistryDimitrios Giannis, Mark Goldin, Husneara Rahman, et al.
Journal of Neurosurgery|October 5, 2019
Cerebrospinal fluid macrophage migration inhibitory factor: a potential predictor of cerebral vasospasm and clinical outcome after aneurysmal subarachnoid hemorrhageKevin Kwan, Orseola Arapi, Katherine E Wagner, et al.
Blood|May 16, 2002
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytesRajendra N Damle, Fabio Ghiotto, Angelo Valetto, et al.
The American Journal of Tropical Medicine and Hygiene|April 7, 2009
Cerebral malaria is associated with low levels of circulating endothelial progenitor cells in African childrenBen Gyan, Bamenla Quarm Goka, George O Adjei, et al.
Annals of the American Thoracic Society|February 25, 2022
Mortality of Mechanically Ventilated COVID-19 Patients in Traditional versus Expanded Intensive Care Units in New YorkMitsuaki Nishikimi, Daniel Jafari, Neha Singh, et al.
American Journal of Physical Medicine & Rehabilitation|November 18, 2021
Challenges and Lessons Learned for Acute Inpatient Rehabilitation of Persons With COVID-19: Clinical Presentation, Assessment, Needs, and Services UtilizationSusan Maltser, Erika Trovato, Heidi N Fusco, et al.
JAMA Internal Medicine|October 7, 2021
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical TrialAlex C Spyropoulos, Mark Goldin, Dimitrios Giannis, et al.
Thrombosis and Haemostasis|April 6, 2021
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID TrialMark Goldin, Dimitrios Giannis, Wassim Diab, et al.
Pageof 5